Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 2462505 approvals

SLSBio(Specialty Lab Solution Bio) Co., Ltd

Official website

Founded 2007, KOSDAQ-listed 2023, SLSBio provides pharmaceutical quality control, drug development support, and in vitro diagnostics.

As of 2026-10-10, SLSBio(Specialty Lab Solution Bio) Co., Ltd has 5 Korean MFDS device approvals on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

SLSBio was established in January 2007 and listed on KOSDAQ in October 2023, operating in pharmaceutical quality control, new drug development support, and in vitro diagnostic devices. The company provides pharmaceutical quality control services including finished drug product quality testing and comparative dissolution testing, and is developing diagnostic kits using its proprietary NTMD technology. Designated by the Ministry of Food and Drug Safety as a contract testing institution, SLSBio operates 320 analytical instruments including LC/MS and UPLC covering approximately 300 test items, with a research organization of 9 staff comprising 2 PhDs, 2 master's degree holders, and 5 bachelor's degree holders.

Products & technology

  • Finished pharmaceutical product quality testingTesting to verify pharmaceutical quality according to standards and test methods approved by the Ministry of Food and Drug Safety
  • Comparative dissolution testingIn-vitro dissolution comparison test between two formulations with the same active ingredient and administration route to demonstrate pharmaceutical equivalence

Regulatory approvals

data.go.kr

5 Korean MFDS device approvals · 2013–2021

  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-07-14
    Product approval · Class 3체외 제허 21-603 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2021-01-21
    Product approval · Class 3체외 제허 21-56 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological method2020-05-21
    Product approval · Class 3체외 제허 20-381 호
  • MFDSIVD reagents for allergy testRevoked2018-08-28
    Product approval · Class 2체외 제인 18-4682 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2013-09-25
    Product approval · Class 3체외 제허 13-1639 호

R&D and key agreements

Source: DART corporate disclosure

NTMD 기술 기반 진단키트 · 체외진단 · 개발 중 · Developing a diagnostic kit using proprietary NTMD technology; human and animal test kits have already been developed

Key disclosures

KRX KIND via OpenDART

Patents

KIPRIS · applicant-matched

AI reads

MAA server logs · IP-verified
32
Times AI engines pulled SLSBio(Specialty Lab Solution Bio) Co., Ltd's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

0
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

32
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

6
live 0
Last 7 days
23
live 0
Last 30 days
32
live 0
All time
  • OpenAIOAI-SearchBot22
  • GoogleGoogleOther4
  • PerplexityPerplexityBot4
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SLSBio(Specialty Lab Solution Bio) Co., Ltd and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Boditech Med Inc.3 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

PROTIA INC.3 shared

KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.

Sugentech, Inc.3 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

GC Medical Science Corporation3 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

SD BIOSENSOR INC.3 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

EuBiologics Co., Ltd.2 shared

KOSDAQ-listed vaccine maker supplying oral cholera vaccine to UNICEF alongside a biologics CRMO business.

HUMASIS CO., LTD.2 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

OSANG HEALTHCARE CO.,LTD.2 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

Median Diagnostics Inc.2 shared

Founded in 1999 and listed on KONEX in 2017, Median Diagnostics develops and manufactures immunoassay, molecular, and point-of-care in vitro diagnostic kits for animal diseases.

RollingStone Co., Ltd.2 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

Access Bio, Inc.2 shared

Founded in 2002 and KOSDAQ-listed in 2013, Access Bio develops rapid diagnostic tests for malaria, COVID-19, and other infectious diseases.

GENEMATRIX INC.2 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition